Suppr超能文献

苯丙氨酸在胰高血糖素生物作用机制中第6位的作用:胰高血糖素的多位点取代类似物

The role of phenylalanine at position 6 in glucagon's mechanism of biological action: multiple replacement analogues of glucagon.

作者信息

Azizeh B Y, Ahn J M, Caspari R, Shenderovich M D, Trivedi D, Hruby V J

机构信息

Department of Chemistry, University of Arizona, Tucson 85721, USA.

出版信息

J Med Chem. 1997 Aug 1;40(16):2555-62. doi: 10.1021/jm960800d.

Abstract

Extensive evidence gathered from structure-activity relationship analysis has identified and confirmed specific positions in the glucagon sequence that are important either for binding to its receptor or for signal transduction. Fifteen glucagon analogues have been designed and synthesized by incorporating structural changes in the N-terminal region of glucagon, in particular histidine-1, phenylalanine-6, and aspartic acid-9. This investigation was conducted to study the role of phenylalanine at position 6 on the glucagon mechanism of action. These glucagon analogues have been made by either deleting or substituting hydrophobic groups, hydrophilic groups, aromatic amino acids, or a D-phenylalanine residue at this position. The structures of the new analogues are as follows: [des-His1, des-Phe6, Glu9]glucagon-NH2 (1); [des-His1,Ala6,Glu9]glucagon-NH2 (2); [des-His1,Tyr6,Glu9]glucagon-NH2 (3); [des-His1,Trp6,Glu9]-glucagon-NH2 (4); [des-His1,D-Phe6,Glu9]glucagon-NH2 (5); [des-His1,Nle6,Glu9]glucagon-NH2 (6); [des-His1,Asp6,Glu9]glucagon-NH2 (7); [des-His1,des-Gly4,Glu9]glucagon-NH2 (8); [desPhe6,-Glu9]glucagon-NH2 (9); [des-Phe6]glucagon-NH2 (10); [des-His1, des-Phe6]glucagon-NH2 (11); [des-His1, des-Phe6,Glu9]glucagon (12); [des-Phe6,Glu9]glucagon (13); [des-Phe6]glucagon (14); and [des-His1, des-Phe6]glucagon (15). The receptor binding potencies IC50 values are 48 (1), 126 (2), 40 (3), 19 (4), 100 (5), 48 (6), 2000 (7), 52 (8), 113 (9), 512 (10), 128 (11), 1000 (12), 2000 (13), 500 (14), and 200 nM (15). All analogues were found to be antagonists unable to activate the adenylate cyclase system even at concentrations as high as 10(-5) M except for analogues 6 and 8, which were found to be weak partial agonists/partial antagonists with maximum stimulation between 6-12%. In competitive inhibition experiments, all the analogues caused a right shift of the glucagon-stimulated adenylate cyclase dose-response curve. The pA2 values were 8.20 (1), 6.40 (2), 6.20 (3), 6.25 (4), 6.30 (5), 6.30 (7), 6.05 (8), 6.20 (9), 6.30 (10), 6.25 (11), 6.10 (12), 6.20 (13), 6.20 (14), and 6.35 (15).

摘要

从构效关系分析中收集到的大量证据已确定并证实了胰高血糖素序列中对于其与受体结合或信号转导很重要的特定位置。通过在胰高血糖素的N端区域引入结构变化,特别是组氨酸-1、苯丙氨酸-6和天冬氨酸-9处的变化,设计并合成了15种胰高血糖素类似物。进行这项研究是为了探究6位苯丙氨酸在胰高血糖素作用机制中的作用。这些胰高血糖素类似物是通过在此位置删除或取代疏水基团、亲水基团、芳香族氨基酸或D-苯丙氨酸残基而制成的。新类似物的结构如下:[去组氨酸-1,去苯丙氨酸-6,谷氨酸-9]胰高血糖素-NH2 (1);[去组氨酸-1,丙氨酸-6,谷氨酸-9]胰高血糖素-NH2 (2);[去组氨酸-1,酪氨酸-6,谷氨酸-9]胰高血糖素-NH2 (3);[去组氨酸-1,色氨酸-6,谷氨酸-9]胰高血糖素-NH2 (4);[去组氨酸-1,D-苯丙氨酸-6,谷氨酸-9]胰高血糖素-NH2 (5);[去组氨酸-1,正亮氨酸-6,谷氨酸-9]胰高血糖素-NH2 (6);[去组氨酸-1,天冬氨酸-6,谷氨酸-9]胰高血糖素-NH2 (7);[去组氨酸-1,去甘氨酸-4,谷氨酸-9]胰高血糖素-NH2 (8);[去苯丙氨酸-6,谷氨酸-9]胰高血糖素-NH2 (9);[去苯丙氨酸-6]胰高血糖素-NH2 (10);[去组氨酸-1,去苯丙氨酸-6]胰高血糖素-NH2 (11);[去组氨酸-1,去苯丙氨酸-6,谷氨酸-9]胰高血糖素(12);[去苯丙氨酸-6,谷氨酸-9]胰高血糖素(13);[去苯丙氨酸-6]胰高血糖素(14);以及[去组氨酸-1,去苯丙氨酸-6]胰高血糖素(15)。受体结合亲和力IC50值分别为48 (1)、126 (2)、40 (3)、19 (4)、100 (5)、48 (6)、2000 (7)、52 (8)、113 (9)、512 (10)、128 (11)、1000 (12)、2000 (13)、500 (14)和200 nM (15)。除了类似物6和8被发现是弱部分激动剂/部分拮抗剂,最大刺激在6 - 12%之间外,所有类似物即使在高达10(-5) M的浓度下也被发现是无法激活腺苷酸环化酶系统的拮抗剂。在竞争性抑制实验中,所有类似物都使胰高血糖素刺激的腺苷酸环化酶剂量反应曲线向右移动。pA2值分别为8.20 (1)、6.40 (2)、6.20 (3)、6.25 (4)、6.30 (5)、6.30 (7)、6.05 (8)、6.20 (9)、6.30 (10)、6.25 (11)、6.10 (12)、6.20 (13)、6.20 (14)和6.35 (15)。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验